Does Novel Biologic Do Enough to Stave Off Type 1 Diabetes?

(MedPage Today) -- Whether teplizumab safely delays clinical type 1 diabetes mellitus (T1D) in at-risk individuals is the issue at hand for the FDA Endocrinologic and Metabolic Drugs Advisory Committee when it meets on Thursday.
Developer Provention...